Objective: Radiation exposure to the general public and patients undergoing diagnostic or therapeutic procedures is of great concern, especially to the medical community. Revision of Nuclear Regulatory Commission rules several years ago yield new recommendations for the administration of therapeutic doses of 131-Iodine that included the release criteria. The guidelines for ambulatory treatment included patient education and radiation safety measures to minimize exposure and contamination. Our goal in this study was to evaluate patient compliance with the radiation safety instruction protocols given to them before the therapeutic dose and monitor radiation levels in different house areas at different times after an ablation therapy of 3700MBq or more.
Patient radiation levels were also monitored after the dose administration and at the time of the home surveys. We defined contamination as any house area with radiation levels above background. Descriptive statistics were used for the analysis of the study population data.
All patients and/or legal guardian signed an Informed Consent; pediatric patients also completed the Assent Form. The study and the protocol were approved IRB and Radiation Safety Committee.
Results
A total of 12 patients were included, 11 women and 1 man with a median age was 53 years .
Tumor histology in 97% of the cases was Papillary and Papillary-Follicular variant. Most of the patients were
Stage 1, T1, N0. One patient had distant metastasis; two had T3-4 tumors (see Table 1 ).
Home location was urban in 75% of the cases;
in two patients the living facilities were very small (studio apartment). None of the patients had a relatives or companion in the house. The majority of the patients had a high school diploma, 33% had a university degree.
Radioiodine doses range from 3441-5994 MBq (See Table 1 Patients with the higher measurements were those with distant metastasis and small living facilities. We could not identify any trends based on education level or in the rural or urban settings.
Discussion
Even though NRC guidelines for the release of patients were revised several years ago, it is still an important concern to the scientific community and to the general public the radiation exposure from patients receiving ambulatory radioiodine therapies. The changes in the regulations allowed patients receiving more than 1110MBq of 131 I to be released from the medical facility if the authorized user presented a plan to his/her licensing authority that the patient is able to conform to reasonable isolation instructions so that no member of the public is likely to be exposed beyond 500mSv.
The evolution of these guidelines has been Either using TLD or GM methods to measure of radiation exposure resulting from the radioiodine ablation doses, all studies seem to agree that a wellinformed patient will minimize the risk of exposure to radiation given by 131 I. If a set of rules for hygiene, and proper isolation precautions are followed, the exposure of family members should not exceed the established 5mSv per year.
Even though these studies provided some indication that household radiation exposure is within current NRC safety levels, the study populations have been limited in numbers and not classified.
Our study group evaluated patients with varied educational levels, rural vs. urban house location and a range of therapeutic doses between 100-160 mCi. No difference was found in exposure rates between rural vs, urban house location or throughout the different educational levels. As found in other studies, the mean exposure rate of patients was higher at 24 hours and decreased significantly at 48-72 hours to levels below 1mSv, even in patients with M1. The living areas with greatest contamination were, as expected, in the bedroom, kitchen trash bin and bathroom and the exposure rates decreased significantly at 48-72 hours.
Our initial goal was to include measurements for other household members in our study, however, after the initial orientation, patients with other household members made arrangements for them to stay elsewhere during the post treatment isolation period.
Although our study included a small sample size, the results confirm that our patients are in compliance with radiation protection instructions, providing further reassurance to our staff and patients that radiation exposure is kept to a minimum when following the ATA and NRC recommendations. In accordance with these recommendations we will continue to provide a detailed, complete set of oral and written instructions before the therapeutic dose. Nevertheless, we believe several adjustments may be required in education strategies and protocols for patients with more extensive disease in order to further reduce exposure. These adjustments may include protective covers for the bedding in those with excessive sweating or salivation at night, as well as trash management strategies and further emphasis on bathroom precautions. We also believe that special care may be required with small living quarters, including measures such as temporarily relocating other household members.
Conclusions:
Patient compliance with radiation protection instructions and NRC release criteria was good, even though our study had a small sample size. Radiation exposure levels in the house areas are safe for relatives and/or companions. Special instructions must be emphasized to minimize contamination in the bed, bathroom and kitchen. Based on the experience at our center, caution is recommended in the release of patients with extensive metastatic disease and doses of 
